Our Healthcare Group is a leading provider of financing and strategic advice to large and established enterprises as well as to earlier-stage growth companies in the healthcare sector.

Mizuho's inventive ideas, deep industry knowledge and superior capital markets execution have made our firm a trusted advisor to companies in the Pharmaceutical, Biotech, Medical Devices and Healthcare Services Sectors.

Capital solutions for every stage of growth

In collaboration with Mizuho's product specialists and Financial Sponsors team, we have led high-profile M&A and acquisition-financing deals as well as growth-stage financings. We provide clients a full suite of capabilities, including debt and equity offerings, leveraged finance, risk-focused derivative solutions, strategic advisory, corporate finance and working capital solutions.


  • Provider of debt and equity financing for some of the largest acquisitions across healthcare including Danaher’s purchase of GE BioPharma, Thermo Fisher Scientific’s acquisition of Qiagen NV, and AbbVie’s acquisition of Allergan plc
  • Strong equity franchise acting as bookrunner on IPOs of PPD, BridgeBio and Evolus and Secondary / Convertible Financings for Assembly BioSciences, Cytokinetics, Wave Life Sciences
  • Active M&A advisory business with recent buyside and sellside transactions for Gilead Sciences Inc. and Halo Pharmaceuticals Inc.
  • Provider of credit to support acquisition financings for Bristol Myers Squibb, Cigna, Danaher, Mylan and Teva Pharmaceuticals
  • Strong partnership with Financial Sponsors Group including go-private financings for Cambrex, AMRI and Envision
  • Strong record of providing clients with Deal Contingent Risk Solutions through partnership with our Risk Solutions and integrated M&A teams




Industry expertise


  • Biotech
  • Pharma
  • Medical Devices
  • Healthcare Services
Back to top